Unlock instant, AI-driven research and patent intelligence for your innovation.

Classical swine fever E2 protein gene, porcine pseudorabies virus gD protein gene and application thereof

A technology of protein and gene fragments, which is applied in the direction of viruses, applications, and viral peptides, can solve the problems of antigen compatibility, inability to distinguish infection from wild strains, and the immune effect is easily interfered by maternal antibodies. Good sex, reduced immunization frequency and stress response, high economic benefit and market prospect

Pending Publication Date: 2022-06-03
成都史纪生物制药有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, when the attenuated live vaccine is used in combination with E2, there are antigen compatibility problems, and there are still problems that wild strains cannot be distinguished, and the immune effect is easily interfered by maternal antibodies.
[0005] In order to effectively prevent the two diseases of classical swine fever and porcine pseudorabies, and at the same time distinguish the infection of wild strains, there have been many studies on related subunit vaccines at home and abroad, but all of them are single vaccines, and there are no reports on CSFV and PRV dual subunit vaccines.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Classical swine fever E2 protein gene, porcine pseudorabies virus gD protein gene and application thereof
  • Classical swine fever E2 protein gene, porcine pseudorabies virus gD protein gene and application thereof
  • Classical swine fever E2 protein gene, porcine pseudorabies virus gD protein gene and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1 Reading swine fever E2 protein, pig pseudo -rabies virus Virus GD protein vaccine and its second -combined vaccine research

[0032] 1 E2, the construction and identification of GD protein transfection plasmid

[0033] The swine fever E2 protein gene with HIS-TAG purified labels is commissioned by the Cingsrui biological synthesis, and the Xmaji and BSTZ1107i enzymes of the Xmaji and BSTZ1107I enzymes of the PCHO1.0 are cloned. See figure 1 Essence The constructed E2 protein granules can be obtained by obtaining 1109bp bands by dual enzyme cutting, and GD protein granules can be obtained by obtaining 1085bp bands by dual enzyme cutting. The gene sequencing E2 and GD protein sequences are the same as the design theoretical sequence. Opinion figure 2 Essence The enzyme cutting system is: 3 μL of GD conversion plasmid, FastDigest bst1107i 1 μl, FastDigest Xmaji 1μL, 10 × FastDigest buffer 2 μl, DDH2O 13 μl; reaction conditions are: 37 ° C for 2 hours.

[0034] Swine ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a swine fever E2 protein gene, a porcine pseudorabies virus gD protein gene and application thereof. The CHO engineering cell line for stably expressing the swine fever E2 protein and the pseudorabies gD protein is successfully constructed by carrying out gene recombination on the swine fever E2 protein and the pseudorabies gD protein without a transmembrane hydrophobic region and constructing the swine fever E2 protein and the pseudorabies gD protein to pCHO1.0 plasmids and carrying out liposome transfection and dual-pressurization screening on the recombinant plasmids. The hog cholera E2 protein and the pseudorabies gD protein expressed by the CHO engineering cell line constructed by the method are good in immunogenicity and high in expression yield, after immunization, clinical serum and diagnosis and purification of hog cholera and pseudorabies in a pig farm are facilitated, and dual prevention can be achieved through one injection. High economic benefits and market prospects are realized.

Description

Technical field [0001] The present invention is a genetic restructuring vaccine technology field, which involves the Swine fever E2 protein gene, pig pseudo -rabies virus GD protein gene and its application. Background technique [0002] Spine fever (CSF) is a highly contact infectious disease caused by the Classical Swine Fevervirus (CSFV). Its main characteristics are acute types of sewage changes, actual organs bleeding, necrosis and The infarction, chronic types of cellulose necrosis of enteritis. Swine fever is one of the main infectious diseases that endanger the pig farming. In the "National Medium- and Long -term Animal Epidemic Prevention Plan (2012-2020)", swine fever is also listed as one of the major animal epidemic diseases that are preferred and controlled. The CSFV genome leader is about 12.3KB, which contains only a large open reading box (ORF), which is translated into a polymer. By processing, it is processed as a structural protein and 3 cystated glycoprotein, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/38C12N15/40C07K14/03C07K14/18C12N15/85C12N5/10A61K39/187A61K39/245A61K39/295A61P31/14A61P31/22C12R1/91
CPCC07K14/005C12N15/85A61K39/12A61P31/14A61P31/22C12N2770/24322C12N2710/16722C12N2770/24334C12N2710/16034C12N2800/107A61K2039/552A61K2039/70Y02A50/30
Inventor 袁雪林岳丰雄刘汉平邓菲欧仁芳牛艺霏范芳芳林艳项聪英
Owner 成都史纪生物制药有限公司